Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ortho-hydroxybenzoic acid or derivative doai
Patent
1987-10-02
1989-12-05
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ortho-hydroxybenzoic acid or derivative doai
A61K 31615
Patent
active
048852880
ABSTRACT:
Pharmaceutical composition, useful for the treatment of drepanocytosis, which contains lysine acetylsalicylate.
REFERENCES:
Chem. Abst-93-125427w (1980), 101-482n (1984).
Osamo, N. et al., "Therapeutic Effect of Aspirin in Sickle Cell Anaemia", Acta Haemat. 66: 102-107 (1981).
Thompson, E. et al., "Pharmacological Actions of Diaspirins, Potential Antisickling Agents: Analgesic and Anti-Inflammatory Effects", Res-Commun-Chem-Pathol-Pharmacol, 1985, 48/3 (381-388).
Chatterjee, R. et al., "Structural Features Required for the Reactivity and Intracellular Transport of bis(3,5-dibromosalicyl)fumarate and Related Anti-Sickling Compounds, etc.", J-Biol-Chem, 1984, 259/23 (14863-14873).
Delaney, E. et al., "Alternative Di Aspirins for Modification of Hemoglobin and Sickle Hemoglobin", Arch-Biochem-Biophys 228 (2), 1984, 627-638.
Martin, J. et al., "Managing the Parturient with Sickle Cell Crisis", Clin-Obstet-Gynecol, 1984, 27/1 (39-49).
Massil, S. et al., "Acylation of Hemoglobin by Aspirin-Like Diacyl Esters", J. Pharm. Sci., 73(7), 1013-14.
Massil, S. et al., "Electrostatic Effects in Acylation of Hemoglobin by Aspirins", J. Pharm. Sci., 1984, 73/12 (1851-1853).
Zago, M. et al., "Treatment of Sickle Cell Diseases with Aspirin", Acta-Haematol, 1984, 72/1 (61-64).
Chang, H. et al., "Comparative Evaluation of Fifteen Anti-Sickling Agents", Blood 1983, Apr. vol. 61(4), 693-704.
Greenberg, J. et al., "Trial of Low Doses of Aspirin as Prophylaxis in Sickle Cell Disease", J. Pediatr., 1983 May, vol. 102 (5), pp. 781-784.
Balcerzak, S. et al., "Preliminary Studies of Continuous Extra-Corporeal Carbamylation in the Treatment of Sickle Cell Anemia", L-Lab-Clin-Med, 1982, 100/3 (345-355).
Bernstein, R. et al., "Some Pharmacologic Inhibitors of Complement Activity", Int-J-Immunopharmacol 4 (4), 1982, 381.
Cheng, L. et al., "Chemical Modification of Hemoglobin in Intact Whose Cells: Morphological Studies by Scanning Electron Microscope", Int. J. Biochem., 14(6), 461-5.
Osamo, N., "Aspirin in Sickle-Cell Anemia", Acta-Haematol, 1982, 68/4 (347).
Ozsoylu, S., "Aspirin in Sickle-Cell Anemia", Acta-Haematol-(Basel), 1982, vol. 68(4), p. 347.
Klotz, I. et al., "Rational Approaches to Chemotherapy: Anti-Sickling Agents", Science, 1981 Aug. 14, vol. 213 (4509, pp. 724-731).
Osamo, N. et al., "Therapeutic Effect of Aspirin in Sickle Cell Anemia", Acta-Haematol-(Basel), 1981, vol. 66(2), pp. 102-107.
Wood, L. et al., "Structural Specificities in Acylation of Hemoglobin and Sickle Hemoglobin by Diaspirins", J-Biol-Chem., 1981, 256/13 (7046-7052).
Chaplin, H. et al., "Aspirin-Dipyridamole Prophylaxis of Sickle Cell Disease Pain Crises", Thromb-Haemostasis, 1980, 43/3 (218-221).
Franklin, I. et al., "The Molecular Basis of Antisickling Agents", Trans-R-Soc-Trop-Med-Hyg, 1980, 74/6 (695-700).
Machlin, J. et al., "Effects of Aspirin and Related Drugs in Vitamin E Deficient Rats", J. Nutr., 110(10), 1958-64.
Zaugg, R. et al., "Modification of Hemoglobin with Analogs of Aspirin", J-Biol-Chem., 1980, 255/7 (2816-2821).
Alkjaersig, N. et al., "Experience with Aspirin-Dipyridamole Prophylaxis in Sickle Cell Disease", Thromb-Haemostasis, 1979, 42/1 (Nr. 0134).
Kokkini, G. et al., "The Design of New Antisickling Drugs", Inserm Symp., vol. date 1978, 9.
Arnow, P. et al., "Aspirin, Hyperventilation, and Cerebellar Infraction in Sickle Cell Disease", Arch-Intern-Med., 1978, Jan., vol. 138(1), pp. 148-149.
Machlin, L., "Vitamin E and Prostaglandins (PG)", Tocopherol, Oxygen Biomembr. Proc. Int. Symp., Meeting date 1977, 179-89.
Noguchi, C. et al., "Inhibition of Sickle Hemoglobin Gelation by Amino-Acids and Related Compounds", Biochemistry 17 (25), 1978, 5455-5459.
Protass, L., "Hyperventilation in Sickle Cell Disease", Arch-Intern-Med., 1978, 138/1 (29).
Walder, J. et al., "Alternative Aspirins as Anti-Sickling Agents Acetyl-345-Dibromo Salicylic Acid", Proc-Natl-Acad-Sci-U.S.A., 74 (12), 1977, 5499-5503.
Alkjaersig, N. et al., "Homostatic Alterations Accompanying Sickle Cell Pain Crises", JLABCLINMED, 1976, 83/3 (440-449).
Laasberg, L. et al., "Effect of Sodium P Amino Salicylate on Oxygen Affinity in Normal Sickle and Fetal Human Blood", J. Pharmacol Exp. Ther., 199 (2), 441-453 (1976).
Bridges, K. et al., "Acetylation of Hemoglobin by Aspirin", Proc. Natl., Symp. Sickle Cell Dis., 1st Meeting Date 1974, 185-6.
Laasberg, L. et al., "P Amino Salicylate Shifts the Dissociation Curve of Normal Sickle and Fetal Blood to the Right", Fed. Proc. 34 (3) 862.
Phadke, M. et al., "Hyperhaemolytic and Vascular Occlusive Crises in Sickle Cell Disease", J. Assoc. Phys. India, 1975, Jan., vol. 23 (1), pp. 41-44.
Hernandez, P., "New Aspects in the Treatment of Sickle Cell Anemia", REVCUBAPEDIAT, 1974, 46/2 (177-181).
Huntsman, R. et al., "Treatment of Sickle-Cell Disease", Br. J. Haematol, 1974, Dec., vol. 28(4), pp. 437-444.
Rabinowitz, Israel et al., "Light Scattering Studies of Retardation of Sickling by Aspirin-Like Drugs", Res. Commun. Chem. Pathol. Pharmacol., 8(2), 417-420.
Ritchey, J., "Sickle Cell Anemia, Effects of Acetylsalicylic Acid and of D-Glucose on Hemoglobin S", Diss. Abstr. Int. B, 1975, 35(10), 4810.
Shamsuddin, M. et al., "Sites of Acetylation of Sickle Cell Hemoglobin by Aspirin", Proc. Natl., Acad. Sci., U.S.A., 71(12), 1974, 4693-7.
Athreya, B. et al., "Aspirin-Induced Abnormalities of Liver Function", Am. J. Dis. Child., 1973, Nov., vol. 126 (5), pp. 638-641.
DeFuria, F. et al., "The Effect of Aspirin on Sickling and Oxygen Affinity of Erythrocytes", PROCNATACADSCI, U.S.A., 1973, 70/12(II), (3707-3710).
Klotz, I. et al., "Acetylation of Sickle Cell Hemoglobin by Aspirin", Proc. Nat. Acad. Sci., U.S.A., 70(5), 1313-15, 1973.
Mullick, F. et al., "Sickle Cell Crisis Associated with Drugs", Arch-Environ-Health, 1973, Apr., vol. 26 (4), pp. 221-222.
Alkjaersig, N., "Experience with Aspirin Dipyridamole Prophylaxis in Sickle Cell Disease", 7th Intl. Congress on Thrombosis and Haemostasis, Thromb Haemostasis 42(1), 1979, 60.
Friedman Stanley J.
Synthelabo
LandOfFree
Pharmaceutical compositions containing lysine acetylsalicylate does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions containing lysine acetylsalicylate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions containing lysine acetylsalicylate will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2034572